Al Esraa Pharmaceuticals

What Al Esraa Pharmaceuticals does

Al Esraa Pharmaceuticals (ALESRAA PHARMACEUTICALS) is a private Egyptian pharmaceutical manufacturer founded in 1996, headquartered in Nasr City, Cairo. The company develops, produces, and distributes prescription medicines, over-the-counter (OTC) products, dietary supplements, and oral care products under branded franchises including Sugarlo (diabetes), Dapablix (diabetes), Caldin (bone health), Babetone (respiratory), and DG (oral care). Manufacturing is conducted at a single multi-dosage-form facility in Egypt with stated annual capacity of 1.8 billion tablets, 303 million capsules, 53 million liquid bottles, 15.8 million lotion bottles, 19 million semi-solid tubes, 13.3 million oral drops/nasal sprays, and 197 million sachets. ALESRAA also holds exclusive distribution rights in Egypt for SiderAL iron supplement products manufactured in Pisa, Italy.

The company's revenue model combines domestic manufacturing of own-brand pharmaceutical and consumer health products with exclusive distribution of imported brands. Distribution to the Egyptian market is executed primarily through Klick For Trading & Distribution, a partner covering both B2B and B2C channels across the country. The go-to-market is hybrid: sales-led pharmacovigilance and practitioner engagement for prescription products, plus channel-partner-led distribution for OTC, supplements, and oral care. The company explicitly aims to serve the MENA region and aspires to rank among the top 20 healthcare corporates in Egypt.

ALESRAA is a small private employer (11-50 staff) with no public revenue disclosure, no disclosed funding rounds, no executive team listed publicly, and minimal social media footprint. It maintains a stated clinical pipeline of 78 projects and operates a pharmacovigilance program, but no patents, trademarks, certifications, or third-party validation signals were found in the input data.

Name

Al Esraa Pharmaceuticals

Legal name

ALESRAA PHARMASEUTICALS

Website

https://esraapharma.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Al Esraa Pharmaceuticals is a private Egyptian pharmaceutical manufacturer founded in 1996, producing prescription drugs, dietary supplements, OTC, and oral care products from a multi-dosage-form facility in Cairo and serving the MENA region via distributor Klick.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Allergy, Sinus & Respiratory (Non-Asthma) (HLAIADAC)

akta.pro secondary industry

Eye, Ear & Nasal Care (HLAIADAF)

Keywords

• Pharmaceutical manufacturing
• Prescription medicines
• Dietary supplements
• Oral care products
• OTC healthcare products

Headquarters

HQ city

Cairo

HQ country

Egypt

HQ region

Africa

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Product Sales: Sale of prescription medicines, over-the-counter products, dietary supplements, and oral care products manufactured in their state-of-the-art facility.
2. Exclusive Distribution Rights: Exclusive distribution of international brands such as SiderAL products (from Pisa, Italy) in the Egyptian market.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels3 records

Core offering

Al Esraa Pharmaceuticals manufactures and distributes prescription medicines, dietary supplements, OTC products, and oral care products from its Cairo-based production facility. The company operates multiple production lines for tablets, capsules, liquids, lotions, oral drops, nasal sprays, semi-solids, and sachets, and also serves as the exclusive Egyptian distributor for SiderAL iron supplements manufactured in Pisa, Italy.

Product overview

Al Esraa Pharmaceuticals operates as a pharmaceutical manufacturer in Egypt serving the MENA region, offering four main product categories: Prescription Products (including Sugarlo and SugarloPlus diabetes medications, Dapablix, antibiotics like Kinomoxi, urological treatments, and dermatological creams), Dietary Supplements (Caldin-C, Caldin Zinc, Babetone syrups, Proctan capsules, vitamin D supplements, and various wellness products), OTC Products (Biotica Cream, Faster Gel, Dox hand sanitizer), and Oral Care Products (DG-Wash mouthwashes and DG toothpaste line including Cavity, Mint, Clove, Charcoal, White, and CARE variants). The company also serves as an exclusive distributor for SiderAL iron supplements from Pisa, Italy. Manufacturing capabilities include tablets (1.8 billion annual capacity), capsules (303 million), bottles (53 million), lotions (15.8 million), tubes (19 million), and sachets (13.3 million). The company maintains a pharmacovigilance program and reports 78 projects in clinical development.

Differentiator

Problem solved

Functional benefit

Brands

• DG-Wash: Oral care product line including fluoride, clove, and menthol variants
• DG

Products and services

• Sugarlo Tablets (50 mg Vildagliptin) Prescription medication containing 50 mg vildagliptin used for diabetes management, targeting healthcare practitioners and patients with type 2 diabetes.
• SugarloPlus Film-Coated Tablets (Vildagliptin + Metformin) Prescription film-coated tablets combining vildagliptin and metformin hydrochloride in three dosage strengths (50/500, 50/850, and 50/1000 mg) for type 2 diabetes treatment.
• Dapablix Film-Coated Tablets Prescription film-coated tablets for diabetes management.
• Kinomoxi Film-Coated Tablets (400 mg Moxifloxacin) Prescription antibiotic medication containing 400 mg moxifloxacin for the treatment of bacterial infections.
• Sympaprost Hard Gelatin Capsule (4/8 mg Silodosin) Prescription hard gelatin capsule containing 4 mg or 8 mg silodosin for the treatment of benign prostatic hyperplasia.
• Bengiride Soft Gelatin Capsule (0.5 mg Dutasteride) Prescription soft gelatin capsule containing 0.5 mg dutasteride for prostate conditions.
• Sildinax Film-Coated Tablets (100 mg Sildenafil) Prescription medication containing 100 mg sildenafil for the treatment of erectile dysfunction.
• Solvazinc Hard Gelatin Capsule (220 mg Zinc Sulphate) Prescription hard gelatin capsule containing 220 mg zinc sulphate heptahydrate (50 mg elemental zinc) for zinc supplementation.
• Rendose Hard Gelatin Capsule (667 mg Calcium Acetate) Prescription hard gelatin capsule containing 667 mg calcium acetate (169 mg elemental calcium) for hyperphosphatemia treatment.
• Lasmacure Cream (Skin Pigmentation) Prescription topical cream containing 0.01% fluocinolone acetonide, 4% hydroquinone, and 0.05% tretinoin for skin pigmentation disorders.
• Caldin-C Film-Coated Tablets (Calcium + Vitamin D3 + C) Dietary supplement containing 1000 mg calcium carbonate (400 mg elemental calcium), 300 mg trimagnesium citrate, 200 I.U. vitamin D3, and 90 mg vitamin C for bone health and calcium supplementation.
• Caldin Zinc Syrup Dietary supplement syrup containing calcium carbonate, magnesium hydroxide, zinc gluconate, and vitamin D3 for mineral supplementation in children and adults.
• Babetone Syrup (Natural Expectorant) Natural expectorant dietary supplement containing thyme, fennel, bee propolis, rose hips extracts, and honey for cough relief in children (3+ years) and adults. A sugar-free variant is also available for diabetic patients.
• Proctan Hard Gelatin Capsules (General Tonic) General tonic dietary supplement containing avena sativa, asian ginseng, ginkgo biloba, L-arginine, and other ingredients formulated to improve general health.
• Dietary Supplements Range (Vitamins, Minerals, Collagen, Nerve & Cognitive Support) Diverse dietary supplement range including vitamin D drops for infants and children, collagen drinkable liquid for skin and joint health, beauty/wellness liquids, nerve and cognitive support capsules, calcium-vitamin D chewable tablets, and other mineral and vitamin formulations for children and adults.
• Biotica Cream Over-the-counter topical cream for consumer self-care use.
• Faster Gel Over-the-counter topical gel for consumer self-care use.
• Dox Hand Sanitizer Gel Over-the-counter hand sanitizer gel for hand hygiene.
• DG Oral Care Line (Toothpaste & Mouthwash) Oral care product line including DG-Wash fluoride, clove, and menthol mouthwash variants, and DG toothpaste variants (Cavity, LONG, CARE for sensitive teeth, Mint, Clove, Charcoal for whitening, and White). The line covers dental caries prevention, fresh breath, sensitive teeth care, and deep cleaning for the Egyptian consumer market.
• SiderAL Iron Supplement Range (Exclusive Distribution) Iron supplement range exclusively distributed in Egypt by Al Esraa Pharmaceuticals, manufactured by SiderAL in Pisa, Italy. Product variants include SiderAL Bimbi Sachet, SiderAL Active Capsule and Sachet, SiderAL Folic Capsule and Sachet (with folic acid), and SiderAL Forte Capsule (high-strength iron).

Quantifiable outcome

• 78 clinical development projects in pipeline

Named customers2 records

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Two partnerships are on record, tiered core.

• Klick For Trading & DistributioncoreChannel Partner/ Reseller/ Distributor · 1 January 2015Klick For Trading & Distribution is a trading company specialized in pharmaceutical industry raw and packing materials as agent/distributor. KLICK is one of ALESRAA's key business pillars, established in 2015 based on pharmaceutical industry experience for more than 15 years. The company serves both B2B and B2C sectors in the entire Egyptian market, believing that customers deserve the best products. Headquarters located in Cairo, Egypt.
• SiderAL (Pisa, Italy)coreChannel Partner/ Reseller/ DistributorALESRAA holds exclusive distribution rights for SiderAL products manufactured in Pisa, Italy. Products include SiderAL Bimbi Sachet, SiderAL Active Capsule, SiderAL Active Sachet, SiderAL Folic Capsule, SiderAL Folic Sachet, and SiderAL Forte Capsule distributed exclusively in the Egyptian market.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Cipla: Global Indian generic pharmaceutical giant with significant respiratory, urology, and OTC presence, including MENA distribution. Comparable on therapeutic mix and dosage-form capabilities, though operating at vastly larger scale.
• Hikma Pharmaceuticals: Jordan-founded, UK-listed multinational with deep MENA presence across branded generics, injectables, and consumer health. Comparable on therapeutic breadth and MENA focus, but at far larger scale and with regulated-market exposure.
• Aurobindo Pharma: Large Indian generic manufacturer with broad prescription and supplement portfolio and established MENA distribution. Comparable dosage-form capabilities (oral solids, liquids, nasal sprays) at much greater scale.

Regional players

• Julphar (Gulf Pharmaceutical Industries): UAE-based pharmaceutical manufacturer with broad generics, OTC, and consumer health portfolio targeting MENA markets. Comparable regional manufacturing peer, though headquartered in the Gulf rather than Egypt.
• SPIMACO Addwaeih: Saudi Arabian pharmaceutical manufacturer producing branded generics, OTC products, and supplements across MENA. Comparable regional pharma manufacturer with similar product categories.

Direct peers

• Pharco Pharmaceuticals: Major Egyptian generic pharmaceutical manufacturer with broad therapeutic coverage (anti-infectives, CNS, cardiovascular) and significant export reach. Directly comparable on prescription-generics model and Egypt-centric manufacturing base.
• EIPICO (Egyptian International Pharmaceutical Industries Company): Largest Egyptian pharma manufacturer by volume, producing a wide range of generics in multiple dosage forms. Directly comparable on multi-format Egyptian manufacturing scale.
• Amoun Pharmaceutical: Leading Egyptian pharma manufacturer with diverse prescription and OTC portfolio plus MENA exports. Comparable on Egyptian manufacturing footprint and breadth of therapeutic categories.
• EVA Pharma: One of Egypt's largest pharmaceutical manufacturers producing prescription, OTC, and consumer health products with multi-country MENA exports. Closest comparable in terms of Egypt-anchored generics plus consumer health portfolio.
• Mepaco Pharma: Egyptian pharmaceutical manufacturer producing generics, OTC products, and dietary supplements in multiple dosage forms. Closely comparable on Egyptian domestic generics plus supplements positioning.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights6 records

Customer concentration

• Xx.com/AlEsraaPharma
• Facebookfacebook.com/AlEsraaPharmaceuticals
• LinkedInlinkedin.com/company/al-esraa-pharmaceutical-optima

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Al Esraa Pharmaceuticals